Bank of America
ADPT icon

Bank of America’s Adaptive Biotechnologies ADPT Stock Holding History

Bank of America’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17M Buy
1,227,917
+421,645
+52% +$6.72M ﹤0.01% 2537
2025
Q4 		$13.1M Sell
806,272
-791,727
-50% -$12.9M ﹤0.01% 2642
2025
Q3 		$23.9M Sell
1,597,999
-259,169
-14% -$3.16M ﹤0.01% 2454
2025
Q2 		$21.6M Buy
1,857,168
+385,615
+26% +$3.5M ﹤0.01% 2481
2025
Q1 		$10.9M Buy
1,471,553
+1,230,557
+511% +$9.46M ﹤0.01% 3046
2024
Q4 		$1.44M Sell
240,996
-538,135
-69% -$2.97M ﹤0.01% 4728
2024
Q3 		$3.99M Sell
779,131
-362,073
-32% -$1.58M ﹤0.01% 3955
2024
Q2 		$4.13M Buy
1,141,204
+623,932
+121% +$1.98M ﹤0.01% 3796
2024
Q1 		$1.66M Buy
517,272
+418,454
+423% +$1.62M ﹤0.01% 4573
2023
Q4 		$484K Sell
98,818
-136,558
-58% -$623K ﹤0.01% 5521
2023
Q3 		$1.28M Buy
235,376
+103,352
+78% +$683K ﹤0.01% 4632
2023
Q2 		$886K Sell
132,024
-313,151
-70% -$2.33M ﹤0.01% 4873
2023
Q1 		$3.93M Buy
445,175
+303,851
+215% +$2.68M ﹤0.01% 3753
2022
Q4 		$1.08M Sell
141,324
-26,053
-16% -$203K ﹤0.01% 4792
2022
Q3 		$1.19M Sell
167,377
-3,298
-2% -$31.1K ﹤0.01% 4744
2022
Q2 		$1.38M Sell
170,675
-38,800
-19% -$341K ﹤0.01% 4619
2022
Q1 		$2.91M Sell
209,475
-23,413
-10% -$368K ﹤0.01% 4202
2021
Q4 		$6.53M Buy
232,888
+44,640
+24% +$1.37M ﹤0.01% 3382
2021
Q3 		$6.4M Sell
188,248
-8,753
-4% -$317K ﹤0.01% 3315
2021
Q2 		$8.05M Buy
197,001
+52,030
+36% +$2.02M ﹤0.01% 3051
2021
Q1 		$5.84M Sell
144,971
-5,778
-4% -$313K ﹤0.01% 3255
2020
Q4 		$8.91M Sell
150,749
-10,631
-7% -$548K ﹤0.01% 2591
2020
Q3 		$7.85M Sell
161,380
-12,513
-7% -$526K ﹤0.01% 2486
2020
Q2 		$8.41M Buy
173,893
+39,891
+30% +$1.45M ﹤0.01% 2369
2020
Q1 		$3.72M Sell
134,002
-54,429
-29% -$1.52M ﹤0.01% 2940
2019
Q4 		$5.64M Buy
188,431
+164,582
+690% +$4.73M ﹤0.01% 3122
2019
Q3 		$736K Buy
+23,849
New +$973K ﹤0.01% 4789

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America's ADPT Position: Q1 2026 in Review

Bank of America increased its Adaptive Biotechnologies (ADPT) stake by 52% in Q1 2026, buying an estimated $6.72M and bringing the position to 1,227,917 shares worth $17M. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

Bank of America first reported a position in ADPT in Q3 2019 and has held it in 27 quarters since. The position peaked at $23.9M in Q3 2025. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Bank of America held 1,227,917 shares of Adaptive Biotechnologies worth $17M as of Q1 2026.
  • Bank of America bought 421,645 Adaptive Biotechnologies shares in Q1 2026, an estimated $6.72M.
  • Adaptive Biotechnologies made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2537 holding.
  • Bank of America first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 27 quarters since.
  • Bank of America's Adaptive Biotechnologies position peaked at $23.9M in Q3 2025.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.